Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer

Clinical trial NCT05034627 · COMPLETED

Trial details

NCT number: NCT05034627
Sponsor: OHSU Knight Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced Pancreatic Adenocarcinoma Metastatic Pancreatic Adenocarcinoma Stage II Pancreatic Cancer AJCC v8 Stage IIA Pancreatic Cancer AJCC v8 Stage IIB Pancreatic Cancer AJCC v8 Stage III Pancreatic Cancer AJCC v8 Stage IV Pancreatic Cancer AJCC v8

Start date: 2022-08-09
Primary completion: 2025-10-07
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.